N

NextGen Healthcare Inc
F:QY1

Watchlist Manager
NextGen Healthcare Inc
F:QY1
Watchlist
Price: 22.2 EUR
Market Cap: 1.5B EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

There is not enough data to reliably calculate the relative value of QY1.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

QY1 Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

2.5
P/S
P/S
Price to Sales
2.5
vs History
vs Industry
Median 3Y
2.3
Median 5Y
2.2
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-259
Median 5Y
-238.6
Industry
22
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-205.8
Median 5Y
12.3
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-15.1
Median 5Y
-8
Industry
19.9
More Details
4.1
P/B
P/B
Price to Book Value
4.1
vs History
vs Industry
Median 3Y
3.7
Median 5Y
3
Industry
2.2
More Details
2.6
EV/S
EV/S
Enterprise Value to Sales
2.6
vs History
vs Industry
Median 3Y
2.4
Median 5Y
2.1
Industry
2.4
More Details
5.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.6
vs History
vs Industry
Median 3Y
5.1
Median 5Y
4.2
Industry
4.9
More Details
40.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
40.5
vs History
vs Industry
Median 3Y
36.7
Median 5Y
23.8
Industry
11.6
More Details
245.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
245.3
vs History
vs Industry
Median 3Y
224
Median 5Y
137.5
Industry
15.9
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-214.6
Median 5Y
11.7
Industry
14.2
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-37.9
Median 5Y
16.2
Industry
17.8
More Details
2.8
EV/IC
EV/IC
Enterprise Value to IC
2.8
vs History
vs Industry
Median 3Y
2.5
Median 5Y
2.1
Industry
1.8
More Details

Multiples Across Competitors

QY1 Competitors Multiples
NextGen Healthcare Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
NextGen Healthcare Inc
F:QY1
1.5B EUR 2.5 -281.1 40.5 245.3
US
Veeva Systems Inc
NYSE:VEEV
45.5B USD 16 58.6 48.8 51.4
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
32.9B AUD 172.3 334.6 234.1 234.1
US
Doximity Inc
NYSE:DOCS
11.9B USD 21.4 52.9 44.4 46.5
JP
M3 Inc
TSE:2413
1.3T JPY 4.5 32 18.3 22
SE
Sectra AB
STO:SECT B
68.5B SEK 33.1 121.6 -150 -150
US
Waystar Holding Corp
NASDAQ:WAY
6.5B USD 6.8 249.3 23 49.2
US
Inspire Medical Systems Inc
NYSE:INSP
3.9B USD 4.7 58.6 60.8 71.5
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
268.2B INR 0 0 0 0
CN
Winning Health Technology Group Co Ltd
SZSE:300253
21.6B CNY 8.2 281.9 98.3 98.3
P/E Multiple
Earnings Growth PEG
US
N
NextGen Healthcare Inc
F:QY1
Average P/E: 138.1
Negative Multiple: -281.1 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
58.6
31%
1.9
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
334.6
38%
8.8
US
Doximity Inc
NYSE:DOCS
52.9
17%
3.1
JP
M3 Inc
TSE:2413
32
N/A N/A
SE
Sectra AB
STO:SECT B
121.6
16%
7.6
US
W
Waystar Holding Corp
NASDAQ:WAY
249.3
N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
58.6
36%
1.6
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
281.9
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
N
NextGen Healthcare Inc
F:QY1
Average EV/EBITDA: 65.6
40.5
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
48.8
38%
1.3
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
234.1
38%
6.2
US
Doximity Inc
NYSE:DOCS
44.4
21%
2.1
JP
M3 Inc
TSE:2413
18.3
13%
1.4
SE
Sectra AB
STO:SECT B
Negative Multiple: -150 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
23
18%
1.3
US
Inspire Medical Systems Inc
NYSE:INSP
60.8
90%
0.7
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
98.3
48%
2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
N
NextGen Healthcare Inc
F:QY1
Average EV/EBIT: 95.7
245.3
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
51.4
39%
1.3
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
234.1
36%
6.5
US
Doximity Inc
NYSE:DOCS
46.5
22%
2.1
JP
M3 Inc
TSE:2413
22
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -150 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
49.2
40%
1.2
US
Inspire Medical Systems Inc
NYSE:INSP
71.5
64%
1.1
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
98.3
47%
2.1

See Also

Summary
QY1 intrinsic value, competitors valuation, and company profile.
DCF Valuation
QY1 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
QY1 stock valuation using valuation multiples.
Wall Street Estimates
QY1 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
QY1 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 266,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.